---
figid: PMC8617922__jcm-10-05305-g001
figtitle: 'Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the
  Burden of the Cytokine Storm'
organisms:
- Mus musculus
- Rattus norvegicus
- Severe acute respiratory syndrome coronavirus 2
- Severe acute respiratory syndrome-related coronavirus
- Homo sapiens
pmcid: PMC8617922
filename: jcm-10-05305-g001.jpg
figlink: /pmc/articles/PMC8617922/figure/jcm-10-05305-f001/
number: F1
caption: Pentoxifylline is able to dampen activation of two major proinflammatory
  signaling pathways (the NFκB and JAK-STAT) via antagonist effect on adenosine binding
  with its receptor (A2AAR). Triggering A2AAR causes elevation of intracellular cAMP
  levels. This leads to increase SUMO-1 activity along with inhibition of the E3 SCF
  Ub ligase complex, which prevents IκBα ubiquitination and degradation, thereby switching
  off the NFκB pathway. Moreover, high cAMP levels suppress cytokine-mediated JAK/STAT
  signaling via induction of the inhibitory protein SOCS3.
papertitle: 'Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding
  the Burden of the Cytokine Storm.'
reftext: Wiktoria Feret, et al. J Clin Med. 2021 Nov;10(22):5305.
year: '2021'
doi: 10.3390/jcm10225305
journal_title: Journal of Clinical Medicine
journal_nlm_ta: J Clin Med
publisher_name: MDPI
keywords: COVID-19 | SARS-CoV-2 | cytokine storm | cytokines | pentoxifylline | pneumonia
  | ARDS | pulmonary fibrosis
automl_pathway: 0.9391633
figid_alias: PMC8617922__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC8617922__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8617922__jcm-10-05305-g001.html
  '@type': Dataset
  description: Pentoxifylline is able to dampen activation of two major proinflammatory
    signaling pathways (the NFκB and JAK-STAT) via antagonist effect on adenosine
    binding with its receptor (A2AAR). Triggering A2AAR causes elevation of intracellular
    cAMP levels. This leads to increase SUMO-1 activity along with inhibition of the
    E3 SCF Ub ligase complex, which prevents IκBα ubiquitination and degradation,
    thereby switching off the NFκB pathway. Moreover, high cAMP levels suppress cytokine-mediated
    JAK/STAT signaling via induction of the inhibitory protein SOCS3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sumo1
  - Nfkb1
  - Kitlg
  - Il6
  - Il6r
  - Socs3
  - SUMO1
  - NFKB1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - KITLG
  - ADRA2A
  - IL6
  - IL6R
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - SOCS3
---
